ARCHIVES

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

This article is from The Cancer Letter archive.

Vol. 25 No. 19 | May 14, 1999

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

Harkin, Bumpers Concerned Over Centers Funding

May 5, 1989

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014

ASCO Honors Eight With Special Awards

May 24, 2002

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010